VEGFR2/Flt3/c-Kit Inhibitor
Inhibition of c-Kit by tyrosine kinase inhibitors | Haematologica
Figure 1 from Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells | Semantic Scholar
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors - ScienceDirect
Distinct cellular properties of oncogenic KIT receptor tyrosine kinase mutants enable alternative courses of cancer cell inhibition | PNAS
Tyrosine Kinase Assay Kits | MBL Life Science -JAPAN-
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors - ScienceDirect
A holistic view on c-Kit in cancer: Structure, signaling, pathophysiology and its inhibitors - ScienceDirect
The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases
The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor - ScienceDirect
Figure 2 from Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells | Semantic Scholar
AZD3229 | 99.99%(HPLC) | In Stock | c-Kit inhibitor
Finding the right KIT inhibitor for advanced systemic mastocytosis | Nature Medicine
List of c-Kit inhibitors | Download Table
Frontiers | Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases
KIT inhibition by tyrosine kinase inhibitors (TKIs). Imatinib, a type... | Download Scientific Diagram
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic t | DDDT
The Proto-oncogene c-Kit Inhibits Tumor Growth by Behaving as a Dependence Receptor
Stem-Cell Factor/c-Kit Inhibitor, ISCK03 | CAS 945526-43-2 | SCBT - Santa Cruz Biotechnology
Computational Analysis of the Binding Specificity of Gleevec to Abl, c-Kit, Lck, and c-Src Tyrosine Kinases | Journal of the American Chemical Society
Biomedicines | Free Full-Text | CD117/c-kit in Cancer Stem Cell-Mediated Progression and Therapeutic Resistance
Role and significance of c-KIT receptor tyrosine kinase in cancer: A review | Biomolecules and Biomedicine
![Cancers | Free Full-Text | Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance](https://www.mdpi.com/cancers/cancers-15-00143/article_deploy/html/images/cancers-15-00143-g001.png "Cancers | Free Full-Text | Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance")
Cancers | Free Full-Text | Identification of Thiazolo[5,4-b]pyridine Derivatives as c-KIT Inhibitors for Overcoming Imatinib Resistance
Figure 3 from Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells | Semantic Scholar
